Christiane D. Fichter

Author

Also Known As

C D Fichter, C Fichter, C. D. Fichter, C.D. Fichter, Christiane D Fichter, Christiane D. Fichter, Christiane Daniela Fichter, Christiane Fichter

Publications

317

Citations

H-Index

Concepts

All Affiliations

University Medical Center Freiburg University of Freiburg German Cancer Research Center Heidelberg University St. Vincentius-Kliniken

About

Christiane D. Fichter is an author at University Medical Center Freiburg specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	130
2	Cell Biology	2	2	87
3	Natural Sciences	1	1	43
4	Biochemistry	1	1	43
5	Molecular Biology	1	1	43

Christiane D. Fichter

Publications

307

Citations

H-Index

Page 1

	Year	Citations
EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer Christiane D. Fichter, Sylvia Timme, Julia A. Braun, International Journal of Cancer	2014	56
STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett’s adenocarcinomas Sylvia Timme, S Ihde, Christiane D. Fichter, Oncogene Cancer ResearchEsophageal CancerMedicinePathologyStat3 Inhibition	2013	52
Stepwise Assembly of Dimeric F<sub>1</sub>F<sub>o</sub>-ATP Synthase in Mitochondria Involves the Small F<sub>o</sub>-Subunits k and i Karina Wagner, Inge Perschil, Christiane D. Fichter, Molecular Biology of the Cell BiosynthesisCellular EnzymologyMitochondrial FunctionBiochemistryProtein Folding	2010	43
Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells Christiane D. Fichter, Corinna Herz, Claudia Münch, BMC Cell Biology	2011	42
ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways Christiane D. Fichter, Verena Gudernatsch, Camilla Maria Przypadlo, Journal of Molecular Medicine Tumor BiologyEsophageal CancerMedicineCancer GrowthAdenocarcinoma Cells	2014	35
ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer Anna-Lena Geißler, Daniel Kottmann, Lisa Lutz, Oncotarget	2017	30
Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells Nour-Imene Zahaf, Alexander E. Lang, Lars Kaiser, Scientific Reports	2017	27
Occurrence of Aurora A positive multipolar mitoses in distinct molecular classes of colorectal carcinomas and effect of Aurora A inhibition Corinna Herz, Fabienne Schlürmann, Daniela Batarello, Molecular Carcinogenesis	2011	12
A new model system identifies epidermal growth factor receptor–human epidermal growth factor receptor 2 (HER2) and HER2–human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion Christiane D. Fichter, Camilla Maria Przypadlo, Achim Buck, The Journal of Pathology	2017	10

Page 1